Clinical aspects and management of AIDS-related lymphoma (Q34292025)

1 August 2017

1 reference

title

Clinical aspects and management of AIDS-related lymphoma (English)

1 reference

primary effusion lymphoma

1 August 2017

main subject

1 reference

Sparano JA

1

1 reference

1 August 2017

publication date

1 July 2001

1 reference

European Journal of Cancer

1 August 2017

published in

1 reference

1 August 2017

volume

37

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1296-1305

1 reference

The association of immune disease and malignant lymphoma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Burkitt's lymphoma in a homosexual

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Primary Central Nervous System Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Autopsy findings in AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Herpesvirus-like DNA sequences selectively cluster with body cavity-based lymphomas throughout the spectrum of AIDS-related lymphomatous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Herpes-Like DNA Sequences in a Body-Cavity–Based Lymphoma in an HIV-Negative Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

HIV-associated primary CNS lymorbidity and utility of brain biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Acquired immune deficiency syndrome-related pulmonary non-Hodgkin lymphoma regressing after zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Complete remission of a primary effusion lymphoma with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 lev

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900111-3

7 January 2021

10.1016/S0959-8049(01)00111-3

Identifiers

DOI

1 reference

1 August 2017

1 reference